Literature DB >> 15094904

Toxocariasis of the central nervous system: with report of two cases.

Sandra F Moreira-Silva1, Murilo G Rodrigues, João L Pimenta, Camila P Gomes, Larissa H Freire, Fausto E L Pereira.   

Abstract

Clinical involvement of the nervous system in visceral larva migrans due to Toxocara is rare, although in experimental animals the larvae frequently migrate to the brain. A review of the literature from the early 50's to date found 29 cases of brain involvement in toxocariasis. In 20 cases, various clinical and laboratory manifestations of eosinophilic meningitis, encephalitis, myelitis or radiculopathy were reported. We report two children with neurological manifestations, in which there was cerebrospinal fluid pleocytosis with marked eosinophilia and a positive serology for Toxocara both in serum and CSF. Serology for Schistosoma mansoni, Cysticercus cellulosae, Toxoplasma and cytomegalovirus were negative in CSF, that was sterile in both cases. Improvement of signs and symptoms after specific treatment (albendazole or thiabendazole) was observed in the two cases. A summary of data described in the 25 cases previously reported is presented and we conclude that in cases of encephalitis and myelitis with cerebrospinal fluid pleocytosis and eosinophilia, parasitic infection of the central nervous system should be suspected and serology should be performed to establish the correct diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15094904     DOI: 10.1590/s0037-86822004000200011

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  21 in total

Review 1.  Cerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?

Authors:  Chia-Kwung Fan; Celia V Holland; Karen Loxton; Ursula Barghouth
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 2.  Neurotoxocariasis: a systematic literature review.

Authors:  S Deshayes; J Bonhomme; Arnaud de La Blanchardière
Journal:  Infection       Date:  2016-03-23       Impact factor: 3.553

3.  Toxocara encephalitis presenting with autonomous nervous system involvement.

Authors:  F Caldera; M E Burlone; C Genchi; M Pirisi; E Bartoli
Journal:  Infection       Date:  2012-09-21       Impact factor: 3.553

4.  Toxocara canis larvae reinfecting BALB/c mice exhibit accelerated speed of migration to the host CNS.

Authors:  Petra Kolbeková; David Větvička; Jan Svoboda; Karl Skírnisson; Markéta Leissová; Martin Syrůček; Helena Marečková; Libuše Kolářová
Journal:  Parasitol Res       Date:  2011-05-03       Impact factor: 2.289

Review 5.  Clinical spectrum of symptoms in cerebral Toxocariasis (Review).

Authors:  Any Docu Axelerad; Alina Zorina Stroe; Anca Elena Gogu; Agneta Pusztai; Dragos Catalin Jianu; Duta Daniel; Daniel Docu Axelerad
Journal:  Exp Ther Med       Date:  2021-03-22       Impact factor: 2.447

Review 6.  Eosinophilia in Infectious Diseases.

Authors:  Elise M O'Connell; Thomas B Nutman
Journal:  Immunol Allergy Clin North Am       Date:  2015-08       Impact factor: 3.479

7.  Neurotoxocarosis alters myelin protein gene transcription and expression.

Authors:  Lea Heuer; Martin Beyerbach; Fred Lühder; Andreas Beineke; Christina Strube
Journal:  Parasitol Res       Date:  2015-03-17       Impact factor: 2.289

Review 8.  Update on eosinophilic meningoencephalitis and its clinical relevance.

Authors:  Carlos Graeff-Teixeira; Ana Cristina Arámburu da Silva; Kentaro Yoshimura
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

9.  Toxocariasis presenting as encephalomyelitis.

Authors:  Gregory Helsen; Stefaan J Vandecasteele; Ludo J Vanopdenbosch
Journal:  Case Rep Med       Date:  2011-05-05

10.  Toxocariasis might be an important cause of atopic myelitis in Korea.

Authors:  Jin-Young Lee; Byoung-Joon Kim; Sang-Pyo Lee; Yun-Jin Jeung; Mi-Jung Oh; Min-Su Park; Jae-Won Paeng; Byung-Jae Lee; Dong-Chull Choi
Journal:  J Korean Med Sci       Date:  2009-11-07       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.